Atlas Trials

Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma

Clinical trial NCT03097328 · COMPLETED

Trial details

NCT number
NCT03097328
Sponsor
Bradley A. McGregor, MD
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Renal Cell Carcinoma
Start date
2017-08-01
Primary completion
2021-07-20
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.